Previous close | 28.72 |
Open | 28.72 |
Bid | 29.02 x 3000 |
Ask | 28.95 x 2900 |
Day's range | 28.67 - 29.05 |
52-week range | 25.20 - 36.29 |
Volume | |
Avg. volume | 32,225,652 |
Market cap | 164.391B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.46 |
Earnings date | 29 Oct 2024 - 04 Nov 2024 |
Forward dividend & yield | 1.68 (5.79%) |
Ex-dividend date | 26 Jul 2024 |
1y target est | 33.01 |
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Pfizer. Inc. (NYSE:PFE) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
Alnylam stock tumbled Friday after the company's Pfizer-rivaling heart disease treatment lagged expectations in a lengthy study.
U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. Already, Pfizer and Moderna are shipping shots modified to better match more recent strains of the ever-evolving coronavirus. Friday, the Food and Drug Administration gave the OK to the updated Novavax formula, too — and those shots are open to anyone 12 and older.